LeMaitre Vascular, Inc. (LMAT) Stock Forecast
Data as of Oct 31, 2026Healthcare · Current price $81.07 (-4.93%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Nov 10, 2025 | Ross Osborn | Cantor Fitzgerald | $95.00 | +17.2% |
| Oct 15, 2024 | Ross Osborn | Cantor Fitzgerald | $96.00 | +18.4% |
| Aug 20, 2024 | Daniel Stauder | JMP Securities | $100.00 | +23.4% |
| Apr 26, 2024 | Rick Wise | Stifel Nicolaus | $75.00 | -7.5% |
| Sep 6, 2023 | Suraj Kalia | Oppenheimer | $70.00 | -13.7% |
Top Analysts Covering LMAT
LMAT vs Sector & Market
| Metric | LMAT | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.40 | 2.25 | 2.41 |
| Analyst Count | 5 | 8 | 19 |
| Target Upside | +41.9% | +153002.0% | +21.5% |
| P/E Ratio | 29.92 | 3.44 | 38.49 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $72M | $73M | $73M | 5 |
| 2027-03-31 | $72M | $73M | $74M | 3 |
| 2027-06-30 | $77M | $78M | $79M | 3 |
| 2027-09-30 | $75M | $76M | $76M | 3 |
| 2027-12-31 | $78M | $80M | $80M | 3 |
| 2028-12-31 | $328M | $329M | $330M | 4 |
| 2029-12-31 | $343M | $350M | $357M | 3 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $0.76 | $0.77 | $0.78 | 4 |
| 2027-03-31 | $0.72 | $0.73 | $0.74 | 2 |
| 2027-06-30 | $0.80 | $0.81 | $0.82 | 2 |
| 2027-09-30 | $0.75 | $0.76 | $0.77 | 2 |
| 2027-12-31 | $0.80 | $0.81 | $0.82 | 2 |
| 2028-12-31 | $3.34 | $3.35 | $3.35 | 3 |
| 2029-12-31 | $0.00 | $0.00 | $0.00 | 1 |
Frequently Asked Questions
What is the analyst consensus for LMAT?
The consensus among 5 analysts covering LeMaitre Vascular, Inc. (LMAT) is Buy with an average price target of $115.00.
What is the highest price target for LMAT?
The highest price target for LMAT is $100.00, set by Daniel Stauder at JMP Securities on 2024-08-20.
What is the lowest price target for LMAT?
The lowest price target for LMAT is $70.00, set by Suraj Kalia at Oppenheimer on 2023-09-06.
How many analysts cover LMAT?
5 analysts have issued ratings for LeMaitre Vascular, Inc. in the past 12 months.
Is LMAT a buy or sell right now?
Based on 5 analyst ratings, LMAT has a consensus rating of Buy (2.40/5) with a +41.9% upside to the consensus target of $115.00.
What are the earnings estimates for LMAT?
Analysts estimate LMAT will report EPS of $0.77 for the period ending 2026-12-31, with revenue estimated at $73M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.